thus , in conclusion , intravenous propranolol testing predicts the therapeutic efficacy of oral nadolol therapy and oral nadolol in once-daily doses may be used for long-term prophylaxis of recurrent supraventricular tachycardia .
C0033497
propranolol
C0039240
supraventricular tachycardia